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Abstract  
 
Objective: To determine whether perfluorocarbon liquid can be condensed from gases containing 
perfluorocarbon vapour and whether the amount recovered varies with background flow rate.  
 
Design and setting: Bench-top experimental study in a neonatal laboratory. Interventions: The 
expiratory limb of a standard ventilator circuit set-up was mimicked, with the addition of a chilled 
water jacket (Liebig) condenser. Perfluorocarbon vapour was passed through the circuit at a 
number of flow rates.  
 
Measurements and results: Perfluorocarbon vapour was passed through the circuit and the 
percentage recovery of liquid measured. More than 60% of the perfluorocarbon vapour was 
recovered at all flow rates (1, 2, 5 and 10 l/min), with significantly higher recovery obtained (up 
to 74%) at low flow rates (1 l/min).  
 
Conclusions: Using a simple condenser, more than 60% of perfluorocarbon liquid can be 
recovered without altering the function of an expiratory limb of a ventilator circuit. 
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Introduction 
There are currently many groups undertaking research in partial and/or total liquid ventilation 
using perfluorocarbon liquids (PFCs). Whilst PFCs seem to be physiologically ideal for liquid 
ventilation, they have two major drawbacks. The first is cost, with perfluorooctyl bromide, the 
most commonly used PFC, costing US $530/kg (Interchim, Montlucon, France) and FC-77 (3M 
Pharmaceuticals, St. Paul, Minn., USA) costing $830/kg. Both of these prices are for industrial 
grade chemicals, neither of which are sterile or sufficiently pure to be used medically. 
 
The second major concern is environmental. All PFCs are photochemically stable and are 
expected to persist in the atmosphere for very long periods. For example, FC-77 is expected to 
persist for more than 1000 years [1]. As such, it has a high global-warming potential, more than 
5,000 times that of carbon dioxide, if a very conservative lifetime of only 100 years is considered 
[1]. This is significantly higher than many of the chlorofluorocarbons, such as refrigerants, 
commonly thought of as major contributors to the greenhouse effect [2]. 
 
For both cost and environmental reasons PFCs used during research should be recovered and 
recycled. Similar measures will need to be undertaken when PFCs are employed clinically. 
Currently 3M recommends that users of FC-77 limit emissions by employing good conservation 
practices and by implementing recovery, recycling and/or proper disposal procedures [3]. No 
similar statement is made for perfluorooctyl bromide. It therefore seems prudent to limit the 
losses of PFC during partial liquid ventilation (PLV), both to prevent PFC vapour entering the 
atmosphere and to use the recovered PFC liquid. As all the lost PFC is in the exhaled gases, an 
opportunity exists to recover the PFC. 
 
 
 
Fig. 1 Experimental apparatus. A 37degrees C water bath; B humidifier chamber; C condensers; D water 
trap; E air inlet; F 4 degrees C water inlet; G water outlet 
 
We examined whether PFC liquid can be recovered from expired gases containing PFC vapour 
and, if so, whether the amount recovered varies with background flow rate. Flow rates suitable for 
use in neonates were studied. 
 
Materials and methods 
The experimental apparatus is shown in Fig. 1. The aim was to mimic the expiratory limb of a 
standard ventilator circuit set-up. A humidifier chamber (MR220, Fisher & Paykel Healthcare, 
Auckland, New Zealand) was immersed in a water bath at 37 degrees C. Room temperature air 
was warmed by passing it through a blood warming coil (Tuta Laboratories, Lane Cove, New 
South Wales, Australia) immersed in the water bath and delivered to the chamber at flows of 1 
l/min, 2 l/min, 5 l/min and 10 l/min. Outlet gas temperature was 35-36 degrees C at all flow rates 
studied. As no sections of the circuit were exposed to room air, room temperature had no 
influence on the studies. 
 
For each test 30 ml of FC-77 (vapour pressure=9.99 kPa at 37 degrees C) [3, 4] was introduced to 
the chamber. Unlike conventional ventilator circuits, the system was not humidified by the use of 
water in the humidifier chamber. The air and vapour from the chamber passed through two series-
connected coaxial ventilator circuits (modified from prototype circuits, 10 mm internal diameter, 
smooth bore, 1 m long, Fisher & Paykel) configured as a Liebig condenser with a condensing 
surface of 0.063 m2. A standard ventilator circuit water trap was placed at the junction of the 
circuits in order to keep it as the lowest point in the circuit. Water at 4degrees C was circulated in 
the outer jackets of the ventilator circuits, thus cooling the circuit and leading to condensation of 
the FC-77 vapour which was collected in the water trap. Air flow was allowed to continue until 
all FC-77 had evaporated from the humidifier chamber. The volume of FC-77 in the water trap 
was measured and the percentage recovery calculated. All measurements were performed in 
triplicate. 
 
Results 
More than 60% of the FC-77 was recovered at all flow rates studied (Fig. 2), with significantly 
higher (analysis of variance, p <0.001) recovery obtained at low flow rates (74% at 1 l/min). With 
no cooling, no FC-77 was recovered. 
 
 
 
Fig. 2 PFC recovery at different flow rates 
 
Discussion 
For economic and environmental reasons it is desirable to minimize the loss of PFCs during 
partial and total liquid ventilation. Loss rates up to 2–6 ml/kg per hour have been reported for 
PLV using perfluorooctyl bromide [5, 6]. Higher loss rates, approx. 7 ml/kg per hour, have been 
reported for the more volatile FC-77 [7]. Thus over 10 l PFC may be lost in an adult patient every 
day. This represents a cost of over $10,000/day if industrial grade PFCs are used, in addition to 
the one-off cost of over $2,000 to fill the lungs to functional residual capacity. Both 
perfluorooctyl bromide (vapour pressure=1.47 kPa at 37 degrees C) [4] and FC-77 (vapour 
pressure=9.99 kPa at 37 degrees C) [3, 4] can be readily condensed from the exhalation line 
during PLV or from the gas exchanger during total liquid ventilation. The amount of vapour 
passing into the exhalation line during PLV depends on factors such as the surface area of the 
PFC-air interface, temperature and flow rate. The same factors affect condensation of the PFC 
vapour. The vapour pressure of the PFC impacts on the efficiency of any condensation system. 
With a lower vapour pressure, less perfluorooctyl bromide is lost during ventilation than with FC-
77. Therefore because perfluorooctyl bromide is of lower vapour pressure it evaporates less 
during PLV but more readily condenses (the condensability of PFC vapour increases as vapour 
pressure decreases). The amount of perfluorooctyl bromide recoverable must be tested in future 
experiments. FC-77 has a density of 1.78 g/cm and is not miscible with water [3]. Water would 
readily condense at 4 degrees C and easily be partitioned from FC-77 in the water trap. The 
recovered PFC can be reused in the same patient. Being hydrophobic, PFCs do not support 
bacterial growth. No chemical  decomposition occurs at body temperature, and biological 
materials do not dissolve in PFCs. As such, the PFCs can easily be washed and filtered for reuse. 
Using a complicated rebreathing system, Schrader et al. [8] obtained a 90% recovery rate for 
perfluorooctyl bromide in animal studies utilizing PLV. Specially designed heat and “moisture” 
exchangers fitted to the endotracheal tube may be also used to minimize PFC loss during PLV, 
with a conservation efficiency of 60% for perfluorooctyl bromide [9]. These methods, however, 
all require highly specialized ventilator circuits or other equipment. We have presented a simply 
made circuit, with only a small surface area, which would not alter the conventional ventilator 
function, yet achieves PFC recovery similar to other methods. Flow rates suitable for neonates 
were studied, and further studies are necessary to determine the PFC recovery that can achieved 
with flow rates and ventilator circuits suitable for paediatric and adult ventilation. 
 
Conclusion 
Using a simple condenser more than 60% of PFC liquid (FC-77) can be recovered without 
altering the function of the expiratory limb of a ventilator circuit. Further development of the 
system could allow reuse of the PFC recovered during PLV; thus curtailing loss of PFC to 
atmosphere and the potential high costs of PLV. 
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